Literature DB >> 2879030

Modulation of the carrier-mediated transport of the Tyr-MIF-1 across the blood-brain barrier by essential amino acids.

W A Banks, A J Kastin.   

Abstract

There is evidence that the carrier-mediated system capable of transporting small, N-tyrosinated peptides [e.g., Tyr-Pro-Leu-Gly-NH2 (N-Tyr-MIF-1) and enkephalins] across the blood-brain barrier is modulated by intraventricularly administered leucine. This raises the possibility that the toxicity of amino acids on the central nervous system may be mediated in part by alterations in blood-brain barrier function. We further examined this action of leucine and extended the investigation to include other essential amino acids. High doses of leucine (30 nM and 100 nM/mouse intraventricularly) were found to inhibit significantly transport of iodinated Tyr-MIF-1 out of the brain. Less consistently, a low dose of leucine (1.0 nM/mouse) stimulated transport. Kinetic analysis indicated that leucine produced an uncompetitive type of modulation, probably interacting with the carrier-ligand complex. Among the other amino acids studied, D-leucine inhibited transport at both 1 nM and 100 nM/mouse, but stimulated transport at 0.1 nM/mouse. The only other significant changes occurred at the high (100 nM) dose of arginine, which stimulated, and methionine, which inhibited, transport. The possibility is proposed that derangements in amino acid metabolism might produce some of their effects on the central nervous system by modulating the blood-brain barrier transport systems for peptides and possibly other substances.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2879030

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

Review 1.  Delivering peptides to the central nervous system: dilemmas and strategies.

Authors:  W A Banks; A J Kastin; C M Barrera
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

2.  Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin.

Authors:  W A Banks; A V Schally; C M Barrera; M B Fasold; D A Durham; V J Csernus; K Groot; A J Kastin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Alpha synuclein is transported into and out of the brain by the blood-brain barrier.

Authors:  Yu-Ting Sui; Kristin M Bullock; Michelle A Erickson; Jing Zhang; W A Banks
Journal:  Peptides       Date:  2014-09-30       Impact factor: 3.750

Review 4.  Peptides and the blood-brain barrier.

Authors:  William A Banks
Journal:  Peptides       Date:  2015-03-21       Impact factor: 3.750

5.  Effect of neurotransmitters on the system that transports Tyr-MIF-1 and the enkephalins across the blood-brain barrier: a dominant role for serotonin.

Authors:  W A Banks; A J Kastin
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.

Authors:  Therese S Salameh; Elizabeth M Rhea; Konrad Talbot; William A Banks
Journal:  Biochem Pharmacol       Date:  2020-08-02       Impact factor: 5.858

Review 7.  The blood-brain barrier as an endocrine tissue.

Authors:  William A Banks
Journal:  Nat Rev Endocrinol       Date:  2019-08       Impact factor: 43.330

8.  Nuclear receptor ligand screening in an iPSC-derived in vitro blood-brain barrier model identifies new contributors to leptin transport.

Authors:  Yajuan Shi; Hyosung Kim; Catherine A Hamann; Elizabeth M Rhea; Jonathan M Brunger; Ethan S Lippmann
Journal:  Fluids Barriers CNS       Date:  2022-09-21

Review 9.  Characteristics of compounds that cross the blood-brain barrier.

Authors:  William A Banks
Journal:  BMC Neurol       Date:  2009-06-12       Impact factor: 2.474

10.  Alpha Adrenergic Induction of Transport of Lysosomal Enzyme across the Blood-Brain Barrier.

Authors:  Akihiko Urayama; Shinya Dohgu; Sandra M Robinson; William S Sly; Jeffery H Grubb; William A Banks
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.